Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate


NuvaRing Deep Vein Thrombosis (DVT)

dvt deep vein thrombosis nuvaringRecent studies from Europe and the United States have linked NuvaRing contraceptive devices to an increased risk of blood clots. These can cause dangerous and painful conditions such as Deep Vein Thrombosis, or NuvaRing DVT. 

A Deep Vein Thrombosis, or DVT, is a blood clot which forms deep inside the body, usually in the thigh, lower leg or arms. While these clots can be a natural defense mechanism used to heal wounds and repair injured blood vessels, they can also form unnecessarily as a result of drug side effects.

Blood clots or DVTs which break free and travel through the circulatory system to other organs such as the heart, lungs or brain can cause serious injury or even death. It is very important to receive treatment if you suspect either.

Some common symptoms of a NuvaRing DVT include:

  • Redness
  • Swelling
  • Warmth
  • Pain or weakness
  • Loss of color, loss of sensation, or paralysis in an arm or leg

Thousands of women have reported complications to the FDA or filed lawsuits for conditions such as NuvaRing DVT.  Although trials for these claims are scheduled to start in early 2013, lawyers are still helping those affected file claims.

If you or a loved one developed a blood clot or DVT after using a NuvaRing device, you may be entitled to substantial compensation. It is important to speak with a lawyer about your legal options. Contact us today.


NuvaRing Shown to Increase Blood Clot Risk by 56%

After receiving more than 1,000 reports of complications among NuvaRing users, the FDA published a study in October of 2011 which linked the devices to as much as a 56% increased risk of blood clots over traditional low-dose estrogen birth control pills.

In May of 2012, the British Medical Journal then published a study from Denmark which also showed that vaginal ring contraceptives like NuvaRing could raise blood clot risks by as much as 90% over oral contraceptives.

Most recently, the New England Journal of Medicine released a study on June 14, 2012 which indicated these contraceptive devices could increase blood clot risks by 2 ½ to 3 times over birth control pills, or 6 times over the risk of no hormone use.

Due to the number of patients filing NuvaRing lawsuits, cases have been consolidated to a special federal court in Missouri. The judge overseeing this litigation recently ordered Merck to disclose evidence which may show that the company knew of risks such as NuvaRing DVT, but failed to warn women using the devices.

Lawyers are available to help those affected, and can discuss whether you qualify for a case and how long you have to take action. Before choosing any lawyer, however, make sure they are qualified for this type of lawsuit and have experience fighting large drug companies.

The DrugRisk Resource Center only recommends law firms that specialize in NuvaRing lawsuits.

For more information on NuvaRing side effects, research and litigation, or to speak with a lawyer, contact us today. We are available 24 hours a day to provide help.

Authored by Chris Schroeder